Aspiral sales expand in Hubei Province, China, with new partner
Melbourne, New York -- Fluence Corporation Limited (ASX: FLC) is pleased to announce another contract award to deliver an MABR-based Aspiral™ smart packaged solution in China. This latest contract win is for a 200 m3/day wastewater treatment plant for a highway service area in Xiaogan, Hubei Province, in China. The project calls for two (2) Aspiral™ L4 units to be commissioned and operational by August 2018. This MABR-based installation is Fluence's second in Hubei Province, following successful commissioning of the first in June 2017.
This is the first contract secured under a framework agreement with Fluence's new local Chinese partner Hubei Communication Investment Intelligent Detection Co., Ltd. (Hubei ITEST). According to the terms of the agreement, following successful testing of this plant, the sale is expected to pave the way for additional Aspiral™ sales in the remaining service areas along the highways in Hubei Province, for which Hubei ITEST is responsible. Fluence is able to meet demand for rigorous timelines for China's wastewater requirements due to its pre-engineered smart packaged systems, which are locally produced in China.
Regarding this sale and cooperation, Ms. Hui Du, Managing Director of Hubei ITEST stated: 'We are pleased to use Fluence's Aspiral™ smart packaged solution, which is based on their proven MABR technology. We anticipate that our cooperation with Fluence will lead to a compelling new solution for wastewater treatment at highway service areas in Hubei Province.'
Fluence Managing Director and CEO Henry Charrabe added: 'We're pleased to be working with Hubei ITEST to expand Aspiral's reach in Hubei Province. The advantages of MABR are especially evident in applications like this, where space is scarce, noise and odour need to be managed, and Class 1A effluent is required. We see large potential for future expansion with Hubei ITEST for similar applications along the many highways in Hubei Province.'